Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs PFIZER - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES PFIZER ALKEM LABORATORIES/
PFIZER
 
P/E (TTM) x 37.5 38.2 98.2% View Chart
P/BV x 6.5 6.0 109.2% View Chart
Dividend Yield % 1.0 1.7 60.6%  

Financials

 ALKEM LABORATORIES   PFIZER
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-23
PFIZER
Mar-23
ALKEM LABORATORIES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3,6254,662 77.8%   
Low Rs2,8353,407 83.2%   
Sales per share (Unadj.) Rs970.1530.0 183.0%  
Earnings per share (Unadj.) Rs84.2136.4 61.7%  
Cash flow per share (Unadj.) Rs110.2159.4 69.1%  
Dividends per share (Unadj.) Rs50.0070.00 71.4%  
Avg Dividend yield %1.51.7 89.2%  
Book value per share (Unadj.) Rs756.4701.0 107.9%  
Shares outstanding (eoy) m119.5745.75 261.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.37.6 43.7%   
Avg P/E ratio x38.429.6 129.7%  
P/CF ratio (eoy) x29.325.3 115.9%  
Price / Book Value ratio x4.35.8 74.2%  
Dividend payout %59.451.3 115.7%   
Avg Mkt Cap Rs m386,207184,576 209.2%   
No. of employees `000NANA-   
Total wages/salary Rs m21,3143,317 642.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m115,99324,248 478.4%  
Other income Rs m2,1611,011 213.8%   
Total revenues Rs m118,15325,258 467.8%   
Gross profit Rs m15,0658,420 178.9%  
Depreciation Rs m3,1041,055 294.2%   
Interest Rs m1,074135 796.4%   
Profit before tax Rs m13,0488,240 158.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,9802,001 148.9%   
Profit after tax Rs m10,0686,239 161.4%  
Gross profit margin %13.034.7 37.4%  
Effective tax rate %22.824.3 94.0%   
Net profit margin %8.725.7 33.7%  
BALANCE SHEET DATA
Current assets Rs m86,06424,933 345.2%   
Current liabilities Rs m37,0716,574 564.0%   
Net working cap to sales %42.275.7 55.8%  
Current ratio x2.33.8 61.2%  
Inventory Days Days3393 34.9%  
Debtors Days Days672 2,937.6%  
Net fixed assets Rs m37,24513,780 270.3%   
Share capital Rs m239458 52.3%   
"Free" reserves Rs m90,20831,616 285.3%   
Net worth Rs m90,44732,073 282.0%   
Long term debt Rs m00-   
Total assets Rs m124,54139,031 319.1%  
Interest coverage x13.262.1 21.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 149.9%   
Return on assets %8.916.3 54.8%  
Return on equity %11.119.5 57.2%  
Return on capital %15.626.1 59.8%  
Exports to sales %14.62.8 514.1%   
Imports to sales %00 0.0%   
Exports (fob) Rs m16,916688 2,459.5%   
Imports (cif) Rs mNA8 0.0%   
Fx inflow Rs m16,916688 2,459.5%   
Fx outflow Rs m4,1908 49,875.0%   
Net fx Rs m12,727679 1,873.2%   
CASH FLOW
From Operations Rs m16,8253,557 473.0%  
From Investments Rs m1,128-361 -313.0%  
From Financial Activity Rs m-17,608-3,458 509.2%  
Net Cashflow Rs m416-262 -159.1%  

Share Holding

Indian Promoters % 56.7 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 24.4 18.2 134.2%  
FIIs % 8.5 3.0 280.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 43.3 36.1 119.9%  
Shareholders   65,184 112,456 58.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ALKEM LABORATORIES vs Pfizer

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Pfizer Share Price Performance

Period ALKEM LABORATORIES Pfizer S&P BSE HEALTHCARE
1-Day -1.18% -4.80% 1.18%
1-Month -0.99% -8.24% -0.75%
1-Year 52.26% 21.78% 61.82%
3-Year CAGR 21.70% -2.07% 18.16%
5-Year CAGR 22.99% 4.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Pfizer share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 56.7% stake in the company. In case of Pfizer the stake stands at 63.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Pfizer.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 50.0 per share. This amounted to a Dividend Payout ratio of 59.4%.

Pfizer paid Rs 70.0, and its dividend payout ratio stood at 51.3%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Pfizer.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.